Drdgold (DRDGF) Common Equity (2017 - 2022)

Drdgold (DRDGF) has disclosed Common Equity for 6 consecutive years, with $351.0 million as the latest value for Q2 2022.

  • Quarterly Common Equity rose 2.97% to $351.0 million in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $351.0 million through Jun 2022, up 2.97% year-over-year, with the annual reading at $351.0 million for FY2022, 2.97% up from the prior year.
  • Common Equity hit $351.0 million in Q2 2022 for Drdgold, up from $340.9 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $351.0 million in Q2 2022 to a low of $100.7 million in Q2 2018.
  • Historically, Common Equity has averaged $241.1 million across 5 years, with a median of $225.6 million in 2020.
  • Biggest five-year swings in Common Equity: rose 1.98% in 2018 and later surged 85.72% in 2019.
  • Year by year, Common Equity stood at $100.7 million in 2018, then surged by 85.72% to $187.1 million in 2019, then grew by 20.59% to $225.6 million in 2020, then skyrocketed by 51.08% to $340.9 million in 2021, then increased by 2.97% to $351.0 million in 2022.
  • Business Quant data shows Common Equity for DRDGF at $351.0 million in Q2 2022, $340.9 million in Q2 2021, and $225.6 million in Q2 2020.